ES
SGYP

Equitec Specialists’s Synergy Pharmaceuticals, Inc Common Stock SGYP Stock Holding History

Equitec Specialists’s Portfolio SGYP Stock Details SGYP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-3,000
Closed -$7K – 121
2017
Q4 		$7K Hold
3,000
– – ﹤0.01% 98
2017
Q3 		$9K Hold
3,000
– – ﹤0.01% 95
2017
Q2 		$13K Buy
+3,000
New +$12.4K ﹤0.01% 95
2017
Q1 		– Sell
-600
Closed -$4K – 115
2016
Q4 		$4K Buy
+600
New +$3.14K ﹤0.01% 108

Other funds holding SGYP

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
HP
Hikari Power Tokyo, Japan $855M AUM 14.24% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
CH
CVI Holdings Wilmington, Delaware $116M AUM 5.68% 1-Year Est. Return

Equitec Specialists's SGYP Position: Q1 2018 in Review

Equitec Specialists sold out of Synergy Pharmaceuticals, Inc Common Stock (SGYP) in Q1 2018, closing a stake of 3,000 shares — an estimated $7K sold.

Equitec Specialists first reported a position in SGYP in Q4 2016 and held it in 4 quarters. The position peaked at $13K in Q2 2017. 147 funds tracked by Wall St. Rank hold SGYP as of Q1 2018.

  • Equitec Specialists reported no remaining Synergy Pharmaceuticals, Inc Common Stock position as of Q1 2018 after selling out during the quarter.
  • Equitec Specialists sold 3,000 Synergy Pharmaceuticals, Inc Common Stock shares in Q1 2018, an estimated $7K.
  • Equitec Specialists first reported a position in Synergy Pharmaceuticals, Inc Common Stock in Q4 2016 and held it in 4 quarters.
  • Equitec Specialists's Synergy Pharmaceuticals, Inc Common Stock position peaked at $13K in Q2 2017.
  • 147 funds tracked by Wall St. Rank held Synergy Pharmaceuticals, Inc Common Stock as of Q1 2018.

Based on Equitec Specialists's 13F filing for Q1 2018, filed 23 May 2018.